Technology News and Research

RSS

EDP Biotech develops a simple blood test for detecting early-stage colon cancer

Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer.

16 Dec 2009

Study may lead to more targeted research and treatment for memory disorders

The conversations neurons have as they form and recall memories have been decoded by Medical College of Georgia scientists.

16 Dec 2009

Cellular Dynamics International launches iCell Cardiomyocytes

Cellular Dynamics International (CDI) today announced the commercial launch of iCell(TM) Cardiomyocytes for use in testing of new drug candidates by the pharmaceutical industry.

16 Dec 2009

Ouroboros Medical receives approval to market its spinal fusion product in Europe

Ouroboros Medical, Inc., an early stage medical device company focused on developing minimally invasive spine products for degenerated disc disease, has received approval to market Ouroboros’s spinal fusion product in Europe.

16 Dec 2009

Italian patent issued for NPM1 to test patients with AML

Xenomics, Inc., a developer of transrenal molecular diagnostics, announced today that a key Italian patent covering a unique diagnostic application with critical significance for patients with acute myeloid leukemia (AML) has issued.

16 Dec 2009

Interactive education program to fight against malaria

ONE and Malaria No More announced today they are accepting applications for the first-ever "Malaria Griots" program, a dynamic education course that will train and educate participants to become leaders in the fight against malaria.

16 Dec 2009

MU researcher says older American women face unique barriers in healthcare

For Americans living in rural areas, obtaining and maintaining health care can be challenging. Aside from common barriers, including shortages of care providers and facilities, older women face additional challenges, according to Kay Libbus, a public health researcher at the University of Missouri. Libbus says that women ages 50-65 living in rural areas are at-risk for inadequate health care coverage and limited access to health information.

16 Dec 2009

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

SRI International, an independent nonprofit research and development organization, announced today the award of U.S. patent 7,592,021 for a new bioadhesive drug delivery system that enables enhanced release of drugs through the human body's mucous membranes.

16 Dec 2009

Researchers develop new electrophoretic method for detecting MIRCERA and EPO in blood

Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA® and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, but does not alter the performance characteristics of SDS-PAGE for detecting other EPOs.

16 Dec 2009

SBi announces new joint venture with Khazanah Nasional Berhad and MTDC

Small Bone Innovations, Inc. (SBi), a leading, privately held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, announced the formation of a joint venture with Khazanah Nasional Berhad (Khazanah) and Malaysian Technology Development Corporation Sdn. Bhd. (MTDC). The joint venture, SBi Asia Pacific Sdn. Bhd. (SBi APAC), is based in Kuala Lumpur, Malaysia.

16 Dec 2009

NovaDel receives Issue Notification from USPTO for oral spray

NovaDel Pharma Inc., today announced that it received an Issue Notification from the United States Patent and Trademark Office (USPTO) for a new U.S. Patent, No. 7632517, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaDel’s oral spray technology.

16 Dec 2009

USPTO issues Notice of Allowance for U.S. patent application in the 'Crooke' patent family

Isis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application (No. 10/078,949) in the “Crooke” patent family, which broadly covers chemically modified RNA-containing therapeutics.

16 Dec 2009

Life Technologies completes previously announced acquisition of BioTrove

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has completed the previously announced acquisition of BioTrove, Inc. for an undisclosed amount.

16 Dec 2009

InSite Vision to advance new development candidate ISV-303

InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.

16 Dec 2009

PatientKeeper closes $13 million round of funding

PatientKeeper, Inc., the leading provider of Physician Information Technology, today announced that it has closed a $13 million round of funding comprised of equity and debt.

16 Dec 2009

Idaho Technology signs licensing agreement with Kapa Biosystems

Idaho Technology, Inc. has signed a licensing agreement with Kapa Biosystems, Inc., covering reagents or methods using SYBR® Green I technology and melting curve analysis for real time PCR.

16 Dec 2009

TRAPPC9 as gene may be associated with intellectual disability world-wide, scientists identify

A gene involved in some forms of intellectual disability has been identified by scientists at the Centre for Addiction and Mental Health (CAMH), as published this month in The American Journal of Human Genetics. The gene is called TRAPPC9.

16 Dec 2009

FDA grants approval to market InterSol platelet additive solution

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal approval to market InterSol® platelet additive solution.

15 Dec 2009

BioAlliance Pharma SA to enter Phase II clinical trial for clonidine Lauriad and Phase I clinical trial for AMEP

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.

15 Dec 2009

Lilly Endowment offers $60 million to implement the Indiana Physician Scientist Initiative

When a patient has a disease that can't be treated effectively, the physician can see clearly where research is needed.

15 Dec 2009

Technology News and Research

EDP Biotech develops a simple blood test for detecting early-stage colon cancer

Study may lead to more targeted research and treatment for memory disorders

Cellular Dynamics International launches iCell Cardiomyocytes

Ouroboros Medical receives approval to market its spinal fusion product in Europe

Italian patent issued for NPM1 to test patients with AML

Interactive education program to fight against malaria

MU researcher says older American women face unique barriers in healthcare

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

Researchers develop new electrophoretic method for detecting MIRCERA and EPO in blood

SBi announces new joint venture with Khazanah Nasional Berhad and MTDC

NovaDel receives Issue Notification from USPTO for oral spray

USPTO issues Notice of Allowance for U.S. patent application in the 'Crooke' patent family

Life Technologies completes previously announced acquisition of BioTrove

InSite Vision to advance new development candidate ISV-303

PatientKeeper closes $13 million round of funding

Idaho Technology signs licensing agreement with Kapa Biosystems

TRAPPC9 as gene may be associated with intellectual disability world-wide, scientists identify

FDA grants approval to market InterSol platelet additive solution

BioAlliance Pharma SA to enter Phase II clinical trial for clonidine Lauriad and Phase I clinical trial for AMEP

Lilly Endowment offers $60 million to implement the Indiana Physician Scientist Initiative

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News